NEW YORK, May 13, 2021 /PRNewswire/ —
The allergy immunotherapies market is poised to grow by USD 713.56 million during 2021-2025, progressing at a CAGR of almost 8% during the forecast period.
Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.
Get FREE Sample Report in Minutes!
The report on the allergy immunotherapies market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by factors such as the increasing prevalence of allergies, the recent approvals, and strong pipeline, and the growing market consolidation.
The allergy immunotherapies market analysis includes the product and geography landscape segments. This study identifies the technological advances in allergy diagnostics as one of the prime reasons driving the allergy immunotherapies market growth during the next few years.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The allergy immunotherapies market covers the following areas:
Allergy Immunotherapies Market Sizing
Allergy Immunotherapies Market Forecast
Allergy Immunotherapies Market Analysis
Companies Mentioned
- Aimmune Therapeutics Inc.
- ALK-Abello AS
- Allergy Therapeutics PLC
- ASIT biotech
- DBV Technologies SA
- HAL Allergy BV
- Jubilant Life Sciences Ltd.
- LETI Pharma SLU
- Merck KGaA
- Stallergenes Greer Ltd.
Related Reports on Health Care Include:
Global Allergy Rhinitis Drugs Market– The allergy rhinitis drugs market is segmented by product (antihistamines, intranasal corticosteroids, immunotherapies, and others) and geography (North America, Europe, Asia, and ROW). Download FREE Sample Report
Global Animal Wound Care Market– The animal wound care market is segmented by application (surgical wound care and traditional wound care) and geography (North America, Europe, Asia, and ROW). Download FREE Sample Report
Key Topics Covered:
Executive Summary
Market Landscape
- Market ecosystem
- Impact of COVID-19 on pharmaceuticals
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020- 2025
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- SCIT – Market size and forecast 2020-2025
- SLIT – Market size and forecast 2020-2025
- Market opportunity by Product
Customer landscape
- Overview
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- Europe – Market size and forecast 2020-2025
- North America – Market size and forecast 2020-2025
- Asia – Market size and forecast 2020-2025
- ROW – Market size and forecast 2020-2025
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Aimmune Therapeutics Inc.
- ALK-Abello AS
- Allergy Therapeutics PLC
- ASIT biotech
- DBV Technologies SA
- HAL Allergy BV
- Jubilant Life Sciences Ltd.
- LETI Pharma SLU
- Merck KGaA
- Stallergenes Greer Ltd.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Report Page: https://www.technavio.com/report/allergy-immunotherapies-market-industry-analysis
View original content to download multimedia:http://www.prnewswire.com/news-releases/global-allergy-immunotherapies-market-to-grow-by-usd-713-56-millionkey-drivers-and-market-forecasts17000-technavio-research-reports-301291419.html
SOURCE Technavio
